| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | https://infiniumpharmachem.com/ | |
| Market Cap | 341.71 Cr. | |
| Enterprise Value(EV) | 331.60 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 6.82 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 36.01 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 37.72 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 39.40 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 6.23 | Calculated using Price: 245.55 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.39 Cr. | 13,916,120 Shares |
| FaceValue | 10 | |
| About Infinium Pharmachem Ltd. | ||
| The company is well focused to Iodine chemistry & this is the only core area of it. It is working as CRAMS, but its domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination. It manufactures & supply wide range of superior quality Iodine Derivatives & API Since 2003. It is also providing fully integrated customized services from R&D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & various other chemical Industries. It supplies range of Iodine derivatives on Order to Made basis only. | ||
| 1 Day |
|
+0.10% |
| 1 Week |
|
-2.75% |
| 1 Month |
|
-0.71% |
| 3 Month |
|
+2.31% |
| 6 Month |
|
+66.19% |
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 20.43 | 48.44 | 66.44 | 55.06 | |
| Return on Capital Employed (%) | 18.89 | 32.14 | 38.88 | 36.74 | |
| Return on Assets (%) | 3.87 | 9.66 | 14.37 | 15.16 |
| Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 4 | 7 | 13 | 23 | 54 | |
| Non Curr. Liab. | 6 | 6 | 14 | 10 | 9 | |
| Curr. Liab. | 12 | 21 | 31 | 37 | 38 | |
| Minority Int. | 0 | 0 | 1 | 1 | 1 | |
| Equity & Liab. | 22 | 34 | 59 | 71 | 102 | |
| Non Curr. Assets | 4 | 9 | 15 | 19 | 20 | |
| Curr. Assets | 18 | 25 | 44 | 51 | 82 | |
| Misc. Exp. not W/O | ||||||
| Total Assets | 22 | 34 | 59 | 71 | 102 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 39 | 71 | 99 | 114 | |
| Other Income | 1 | 1 | 1 | 1 | |
| Total Income | 39 | 71 | 100 | 116 | |
| Total Expenditure | -36 | -66 | -89 | -98 | |
| PBIDT | 3 | 6 | 11 | 17 | |
| Interest | -1 | -1 | -2 | -3 | |
| Depreciation | -1 | -1 | -1 | -1 | |
| Taxation | 0 | -1 | -2 | -3 | |
| Exceptional Items | |||||
| PAT | 1 | 3 | 7 | 10 | |
| Minority Interest | 0 | 0 | -1 | 0 | |
| Share Associate | |||||
| Other Related Items | |||||
| Consolidated Net Profit | 1 | 3 | 6 | 9 | |
| Adjusted EPS | 1 | 3 | 6 | 9 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 3 | 7 | 12 | 9 | |
| Cash Fr. Inv. | -1 | -5 | -7 | -5 | |
| Cash Fr. Finan. | -1 | -1 | -2 | -3 | |
| Net Change | 1 | 1 | 3 | 1 | |
| Cash & Cash Eqvt | 1 | 2 | 5 | 6 |
|
No Corporate Announcement found. |
| Fri, 08 Dec 2023 |
High Delivery Percentage
|
Opening at High
|
High Increase in 6 Months
|
Closing Near 20 SMA
|
CCI Trending Up
|
Equities
M.F.
Sectors
StockEdge Social